Management of retinitis pigmentosa by Wharton’s jelly derived mesenchymal stem cells: preliminary clinical results | Stem Cell Research & Therapy | Full Text

Management of retinitis pigmentosa by Wharton’s jelly derived mesenchymal stem cells: preliminary clinical results | Stem Cell Research & Therapy | Full Text

Management of retinitis pigmentosa by Wharton’s jelly derived mesenchymal stem cells: preliminary clinical results

The aim of this study is to determine if umbilical cord Wharton’s jelly derived mesenchymal stem cells implanted in sub-tenon space have beneficial effects on visual functions in retinitis pigmentosa patients ...

Authors:Emin ÖZMERT and Umut ARSLAN

Citation:Stem Cell Research & Therapy 2020 11:25

Content type:Research

Published on: 13 January 2020

• ViewFull Text
 
• ViewPDF